期刊文献+

MUC1粘蛋白—肿瘤生物治疗的新靶点 被引量:9

在线阅读 下载PDF
导出
摘要 MUC1粘蛋白是一种高分子量糖蛋白 ,存在于正常腺细胞和多种癌细胞表面 ,由于它特有的免疫学特性 ,即在癌变细胞表面异常、高度表达 ,具有肿瘤特异性抗原 ,并可非MHC限制性活化CTL ,使之成为肿瘤生物治疗的一种理想靶分子。目前已有多项基于MUC1进行的有关研究 ,有些已用于临床 ,本文将近些年在MUC1肿瘤生物治疗方面的研究做一综述。
出处 《国外医学(免疫学分册)》 2000年第2期113-115,共3页 Foreign Medical Sciences(Section of Immunology Foreign Medical Sciences)
基金 国家自然科学基金!( 3 9670 686)
  • 相关文献

参考文献1

  • 1O. D. M. Hughes,M. C. Bishop,A. C. Perkins,M. Frier,M. R. Price,G. Denton,A. Smith,R. Rutherford,P. A. Schubiger. Preclinical evaluation of copper-67 labelled anti-MUC1 mutin antibody C595 for therapeutic use in bladder cancer[J] 1997,European Journal of Nuclear Medicine(4):439~443

同被引文献83

  • 1鲁藜,邓华瑜,郑维萍,段红.MUC1与人乳腺癌细胞粘附能力关系的体外研究[J].重庆医科大学学报,2004,29(6):742-744. 被引量:1
  • 2Hasholzner U, Stieber P, Reiter W, et al. CA242in comparison with estab- lished tumor markers in colorectal, pancreatic and lung cancer. Anticancer Res, 1999 19 2477.
  • 3Taylor-Papadimitriou J, Burchell J, Miles DW, et al. MUC1 and cancer [J]. Biochim Bionhvs Acta,1999, 1455: 301-313.
  • 4Samuel J, Budzynski WA, Reddish MA, et al. Immunogenicity and antitumour activity of a liposomal MUC1 peptide based vaccine[J]. Int J Cancer, 1995, 75: 295-302.
  • 5Karanikas V, Hwang LA, Pearson J, et al. Antibody and T cell responses of patients with adenocareinoma immunised with mannan MUC1 fusion protein [J]. J Clin Invest, 1997, 100 (11) : 2738-2792.
  • 6Gilewski T, Adluri S, Ragupathi G, et al. Vaeccination of high-risk breast cancer patients with mucin-1 keyhole limpet hemocyanin conjugate plus QS-21 [J]. Clin Cancer Res, 2000, 5: 1693-1701.
  • 7Takahashi T, Makiguehi Y, Hinoda Y, et al. Expression of MUC1 on myeloma cells and induction of HLA-unrestrieted CTL against MUC1 from a multiple myeloma patient [ J]. J Immunol, 1994,153 : 2102-2109.
  • 8Apostolopoulos V, Karanikas V, Haurum JS, et al. Induction of HLA-A2 restricted CTLs to the mucin 1 human breast cancer antigen [J]. J Immunol, 1997, 159: 5211- 5218.
  • 9Wei YQ. Immunotherapy of tumor with vaccines based on xenogeneious homologous molecules [ J]. Anticancer Drugs, 2002, 13( 3 ) : 229-235.
  • 10Melina SM, Mehta V, Finn OJ. Three different vaccines based on the 140-amino acid MUClpeptide with seven tandemly repeated tumor specific epitopes elicit distinct immune effector mechanisms in wildetype versusMUCl-transgenic mice with different potential for tumor rejection [J]. J Immunol, 2001, 18: 6555..6563.

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部